Rectal endometriosis and prolactinoma
letter
OA: bronze
CC0
⤵ 4 in-corpus citations
AI-generated summary
This paper examines the relationship between rectal endometriosis and prolactinoma, two distinct medical conditions.
One-sentence paraphrase of the abstract; not a substitute for reading it. No clinical advice. How this works
My notes (saved in your browser only)
Condition tags
MeSH descriptors
Citation neighborhood (sparse)
Too few in-corpus citations on either side for a chart; here are the lists.
Cites (4)
- Endometriosis of the Intestinal Tract 2001
- Aggressive surgical management for advanced colorectal endometriosis 1994
- Accuracy of magnetic resonance imaging and rectal endoscopic sonography for the prediction of location of deep pelvic endometriosis 2007
- Dopamine agonist administration causes a reduction in endometrial implants through modulation of angiogenesis in experimentally induced endometriosis 2009
Cited by (4)
- Effects of hyperprolactinemia treatment with the dopamine agonist quinagolide on endometriotic lesions in patients with endometriosis-associated hyperprolactinemia 2010
- Use of dopamine agonists to target angiogenesis in women with endometriosis 2020
- The Interplay Between Prolactin and Reproductive System: Focus on Uterine Pathophysiology 2020
- Treatment of Endometriosis with Non-Hormonal Agents: Review 2016
References (5)
- Accuracy of magnetic resonance imaging and rectal endoscopic sonography for the prediction of location of deep pelvic endometriosis via openalex
- Aggressive surgical management for advanced colorectal endometriosis via openalex
- Dopamine agonist administration causes a reduction in endometrial implants through modulation of angiogenesis in experimentally induced endometriosis via openalex
- Endometriosis of the Intestinal Tract via openalex
- W44054814 via openalex
Cited by (4)
- The Interplay Between Prolactin and Reproductive System: Focus on Uterine Pathophysiology 2020
- Use of dopamine agonists to target angiogenesis in women with endometriosis 2020
- Treatment of Endometriosis with Non-Hormonal Agents: Review 2016
- Effects of hyperprolactinemia treatment with the dopamine agonist quinagolide on endometriotic lesions in patients with endometriosis-associated hyperprolactinemia 2010
Source provenance
- europepmc
- last seen: 2026-08-11T06:11:44.160905+00:00
- openalex
- last seen: 2026-06-10T17:14:06.276822+00:00
- pubmed
- last seen: 2026-05-13T22:17:12.951333+00:00
License: CC0
· commercial use OK